CVRx, Inc.
CVRX
NASDAQ·Healthcare·Medical - Devices·Mkt cap $80.9M
$3.05
▲ +1.33%
P/E
-1.54
Mkt Cap
$80.9M
52-Wk Range
$2.20–$11.30
52-Week Range
$2.20 - $11.30
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 61.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary baroreceptor activation therapy with differentiated mechanism of action
- Clinical evidence demonstrating symptom improvement in systolic heart failure patients
- Established FDA approval and expanding international regulatory clearances
- Growing installed base and reimbursement coverage strengthening market penetration
Bear Case
1 risk
- Low volatility (beta 0.8).
Growth
Stable outlook
Rising heart failure prevalence and aging global population increasing addressable market
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Falling
-43.5% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CVRX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 6, 2026
Reported EPS of -$0.53 vs -$0.52 consensus (-1.0% surprise). Revenue of $15.7M vs $15.5M expected (+1.0%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-1.0%
Revenue trend · last 8Q
—
+36%
+15%
+15%
+10%
+4%
+20%
+16%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$13.4M
$15.3M
$12.3M
$13.6M
$14.7M
$16.0M
$14.8M
$15.7M
Margins · last 8Q
Gross
87.4%
Operating
-82.9%
Profit
-89.4%
Wall Street consensus
4 analysts · 25% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
25%
Hold
50%
Sell
25%
Median Price Target
—
Latest: Craig-Hallum · Aug 7, 2026
vs Industry
How CVRX stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related